Nymox Pharmaceutical

NYMXF

OTCHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-5.54M

EBITDA$-5.3M

EBIT$-5.54M

Pre-tax Income$-7.92M

Net Income$-5.55M

Net Cash$740K

Cash Equivalent$351K

Total Debt$114K

Net Debt$-626K

Book Value$-1.8M

Net Cash Per Share0.01

Book Value Per Share-0.02

Return on Equity (ROE)-546.05%

Return on Assets (ROA)-1410.53%

Return on Invested Capital (ROI)-455.04%

Net Profit Margin-117400.00%

Current Ratio0.16

Quick Ratio0.16

Long-Term Debt / Equity0.00